Tag: blood clots
-
September 2013 NuvaRing Update By Merck Reveals More Than 1,700 Lawsuits Filed Since This Products Liability Litigation Started In 2007
Serious Injury And Death Cases Involve Blood Clots Leading To DVT And/Or PE Events As Well As Heart Attacks And Strokes In Women Of Various Ages (Posted by Tom Lamb at DrugInjuryWatch.com)______________________________________________________________________________ UPDATE:"Merck to…
-
October 2013 NuvaRing Label Change: Warnings And Precautions Section Sets Forth Two Competing Medical Studies About Side Effects
In Addition, The New Package Insert No Longer States It Is Unknown If NuvaRing Has A Different Blood Clot (VTE) Risk Than Some Birth Control Pills (Posted by Tom Lamb at DrugInjuryWatch.com) On October…
-
Higher Risk Of Venous Thrombosis – Blood Clot Side Effects Like DVT And PE With YAZ / Yasmin Birth Control Pills Is Confirmed By September 2013 BMJ Medical Journal Article
As With So-Called "Third Generation" Oral Contraceptives, For Drospirenone (DRSP) Containing Pills The Risk Is 50% To 80% Higher Than Levonorgestrel Pills (Posted by Tom Lamb at DrugInjuryWatch.com)On September 12, 2013 the well-known BMJ medical journal…
-
YAZ / Yasmin / Ocella / Gianvi Blood Clot Lawsuits That Are Not Settled Yet: Number Increases, Indicating That These Legal Claims Continue To Be Filed In 2013
Bayer Has Paid $1.4 Billion In Settlements for Cases Involving Deep Vein Thrombosis (DVT) And/Or Pulmonary Embolism (PE), Also Called "Venous Clot Injuries" (Posted by Tom Lamb at DrugInjuryWatch.com)Previously, we reported that more than…
-
Summer 2013 Bayer Lawsuits Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits Continue To Be Settled, With New Cases Being Filed
Bayer Financial Report Shows That More Than 2,500 Venous / Blood Clot Cases (DVT and/or PE) Do Not Have Settlement Agreements As Of April 15, 2013 (Posted by Tom Lamb at DrugInjuryWatch.com)From the "Product-related litigations"…
-
As Bayer Settlements For YAZ, Yasmin, Ocella, And Gianvi Continue In 2013, Total Payments Will Go Over The $1 Billion Level
According To Bayer 2012 Annual Report, More Than 3200 Blood Clot Claims Remain Unsettled And Additional Lawsuits Are Anticipated By Drug Company (Posted by Tom Lamb at DrugInjuryWatch.com)To start, by my review, there is…
-
Some Newer Contraceptive Methods Such As NuvaRing And YAZ / Yasmin Are Under Increasing Scrutiny Over In Europe
Is The FDA Doing Enough About Birth Control Products That Contain Third Generation Or Fourth Generation Progestins And Are Associated With Higher Risks Of Blood Clots (Posted by Tom Lamb at DrugInjuryWatch.com) A January 3,…
-
November 2012 Litigation And Settlements Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits
Bayer Has Settled Less Than Half The DVT And PE Blood Clot Claims Filed Or Cases Subject To Tolling Agreements (Posted by Tom Lamb at DrugInjuryWatch.com) In late October 2012 we received the Bayer Stockholders’ Newsletter…
-
2012 FDA Report On Beyaz Points Out That Younger Women and Girls Are Most At-Risk For Blood Clots
Approved By FDA In 2010, There Has Been No Study Done Yet Regarding Beyaz Safety — Despite Significant Number Of Beyaz Adverse Event Reports (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: FDA Meeting…